Objective. To compare 2 composite indices of sleep apnea disease burden with the commonly used apnea-hypopnea index with regard to baseline measurement of subjective and objective disease burden.
Background
Obstructive sleep apnea is defined by a single polysomnography measure, the apnea-hypopnea index (AHI). Diagnosis of obstructive sleep apnea syndrome requires AHI ≥5 (at least 5 apneas + hypopneas per hour of sleep) associated with subjective symptoms. 1 However, AHI cutoffs used in practice are variable, as is the definition of hypopnea. 2 Differences in equipment between sleep laboratories also contribute to AHI variability. This lack of standardization hinders comparisons of disease severity and therapeutic outcomes between different clinical and research settings.
Furthermore, AHI appears to be an incomplete measure of disease severity, correlating poorly with measures of health status, quality of life, function, and symptoms at baseline and after treatment, thus not fully reflecting sleep apnea health burden or treatment effects. 3, 4 Similarly, the utility of AHI in research is unclear, particularly in evaluating surgical interventions. 4, 5 For chronic disorders such as sleep apnea, it is important to include both subjective (ie, patient-perceived) and objective measures of disease burden. Few such conceptual models for measuring sleep apnea disease burden comprehensively exist in the literature. 6, 7 In keeping with this need, and as an alternative to AHI, we studied the more comprehensive Sleep Apnea Severity Index (SASI) proposed by Piccirillo et al 8 in a 1998 study funded by the American Academy of Otolaryngology-Head & Neck Surgery. SASI incorporates diverse aspects of sleep apnea, including anatomic (redundant pharyngeal mucosa), anthropometric (body mass index), subjective (daytime sleepiness reflected by the Epworth Sleepiness Scale), and physiologic (AHI and lowest oxyhemoglobin saturation) elements (Figure 1) . By considering both objective and patient-centered subjective data, SASI may offer a more holistic view of a sleep apnea patient's status. Despite this potential, it has not been evaluated further and has not been incorporated in clinical practice or research.
This study aimed to evaluate SASI through a crosssectional construct validation. We also evaluated the Modified SASI, first proposed here, in which redundant pharyngeal mucosa is replaced by tonsil size. Redundant pharyngeal mucosa lacks a standardized definition or measurement and risks decreasing reliability between examiners, whereas tonsil size grading is standardized 9 and shows intra-and interobserver reproducibility. 10 We hypothesized that SASI and Modified SASI would each be more strongly associated than AHI with 7 measures (constructs) of sleep apnea disease burden, reflecting more completely this complex disease.
Methods

Study Design
This cross-sectional study analyzed Seattle Sleep Cohort participants at the University of Washington Sleep Disorders Center at Harborview Medical Center, Seattle, Washington. Participants were recruited between August 2006 and October 2007. All participants were recruited and all data collected on the night of their first diagnostic polysomnography.
Participants
Patients were eligible if they presented to the sleep laboratory for overnight polysomnography for undiagnosed but suspected obstructive sleep apnea, successfully completed polysomnography, had linguistic and cognitive ability to answer questionnaires and give informed consent, and were 18 years or older. Patients were excluded for prior diagnosis of sleep apnea, other upper airway obstructive disease, or neurologic, neuromuscular, or pulmonary disease. Patients with either full-night or split-night polysomnography were included in the study. This study was approved by the University of Washington institutional review board.
Data Collection
Consenting participants answered the Sleep Apnea Quality of Life Index, Short Form-36 (SF-36), Epworth Sleepiness Scale, and Pittsburgh Sleep Quality Index. Trained research assistants administered these instruments in a standardized fashion and performed standardized physical examinations, including height, weight, presence or absence of redundant pharyngeal mucosa, and tonsil size. Body mass index was calculated from height and weight measurements. Blood pressures were obtained from the chart for each patient's most recent sleep clinic visit or from automated blood pressure measurements as part of the physical examination at the time of enrollment. Following the physical examination, patients underwent scheduled diagnostic polysomnography, from which AHI, lowest oxyhemoglobin saturation, and desaturation index data were extracted. All patients underwent overnight, monitored, in-laboratory polysomnography. On the morning after polysomnography, patients underwent phlebotomy for a high-sensitivity serum C-reactive protein assay.
SASI scores were calculated as described previously, 8 producing a score of I (lowest sleep apnea severity) to III (highest sleep apnea severity). Modified SASI scores were calculated in a similar fashion, substituting tonsil size for redundancy of pharyngeal mucosa. Tonsil size was graded as 0 for surgically absent tonsils and 1 to 4 for percentage distance from faucial arch to midline (1 = 0%-25%, 2 = 25%-50%, 3 = 50%-75%, and 4 = 75%-100%). Tonsil size was converted to a binary variable, with 0-1 coded as normal and 2-4 coded as enlarged.
When split-night (combined diagnostic and continuous positive airway pressure titration) polysomnography studies were performed (N = 15), only data from the diagnostic portion (mean sleep time ± standard deviation = 145 ± 23 minutes) were analyzed for this study. All polysomnography tests were performed in the sleep laboratory and monitored, and they included recordings of sleep state parameters (4-lead electroencephalogram, bilateral electro-oculogram, and submental and bilateral leg electromyogram), breathing (oronasal airflow by nasal pressure transducer and oronasal thermister, as well as thoracic and abdominal excursion by strain gauge), oximetry, electrocardiogram, and infrared video. All studies were manually scored in standard fashion by trained technicians and confirmed by board-certified sleep physicians.
Apnea was defined as an 80% to 100% reduction in airflow lasting ≥10 seconds. Hypopnea was defined as a 30% to 80% reduction in airflow lasting ≥10 seconds (an associated desaturation or arousal was not required). Apnea-hypopnea index was defined as the number of apnea and hypopneas per hour of sleep and was categorized as normal (0-4.9), mild (5-14.9), moderate (15-29.9), or severe (≥30). Lowest oxyhemoglobin saturation was defined as lowest oxygen saturation during sleep. Desaturation index was defined as number of desaturations ≥3% from baseline per hour of sleep.
Measures of Sleep Apnea Burden (Construct Validation Measures)
Seven construct validation measures were used to measure sleep apnea disease burden. Four measures addressed subjective, patient-centered aspects of disease burden, whereas 3 addressed objective, physiological burden. Because the subjective experience of sleep apnea drives patients to seek care, we decided a priori to place greater importance on subjective measures. In order of priority, these measures were (1) Sleep Apnea Quality of Life Index, 11 13 The bootstrapped distribution data enabled us to test the hypothesis that the SASI (or Modified SASI) had a stronger correlation than AHI for each construct, using the paired t test. A P value <.01 was considered statistically significant, and a P value .01 to .10 was considered a statistical trend; we used a significance level lower than the usual .05 to minimize the potential problem of multiple comparisons.
Role of the Funding Source
Funding sources had no involvement in study design, data collection, analysis, or interpretation. The timing and final decision to submit this manuscript for publication were based solely on the authors' judgment.
Results
Participants included 292 consecutive patients who consented and enrolled in this study. One patient was excluded because of a diagnosis of Rosai-Dorfman disease, which might confound associations with C-reactive protein levels. Necessary data were available for 216 participants included in the final analysis. The study sample demographic characteristics included age 46 ± 11 years, 56% male, and 87% white. The components of the SASI and Modified SASI for the sample included redundant pharyngeal mucosa present in 19%, enlarged tonsils (size ≥2) present in 34%, body mass index 34 ± 8 kg/m 2 , Epworth Sleepiness Scale 10 ± 5, AHI 54 ± 31 events per hour, and lowest oxyhemoglobin saturation 86% ± 9%. The final sample was not significantly different from the total consenting population in any of these characteristics, annual income, or education level (data not shown). The distribution of sleep apnea severity was more balanced for the SASI and the Modified SASI than for AHI ( Table 1) .
The construct validation measures summarized in Table 2 showed some associations with each other. Most notably, the 4 subjective validation variables appeared to be somewhat correlated (absolute value of mean correlation strength 0.44 ± 0.24; range, 0.13-0.70). Subjective and objective measures did not appear to be associated (absolute value of mean correlation strength 0.11 ± 0.12; range, 0.01-0.39), and objective validation measures were not clearly associated with each other (absolute value of mean correlation strength 0.17 ± 0.08; range, 0.08-0.24). The association between each measure of sleep apnea severity and each sleep apnea disease burden construct is shown in Table 3 . The apnea-hypopnea index was not significantly associated with any subjective construct validation measures but was associated (statistical significance or trend) with all objective construct measures. Both SASI and Modified SASI were associated (statistical significance or trend) with 3 of 4 subjective construct measures and all 3 objective construct measures. Both SASI and Modified SASI showed clinically important associations (r ≥ 0.25) or nearly important associations (r ≥ 0.15) with 6 of 7 construct validation measures, whereas AHI did so only with the 3 objective construct validation measures.
Bootstrapping allowed direct comparison between strengths of association of AHI, SASI, and Modified SASI with each construct validation measure ( Table 4 ). Comparisons were performed only for validation measures with which at least 1 overall disease severity measure (SASI, Modified SASI, or AHI) showed significant association, because comparison between insignificant associations was not thought useful or meaningful. SASI and Modified SASI were significantly more strongly associated than AHI with sleep apnea-specific quality of life, vitality status, sleep quality, and serum C-reactive protein. The apnea-hypopnea index was significantly more strongly associated than SASI or Modified SASI with mental health status and desaturation index and more strongly than SASI with mean arterial pressure. However, there was no significant difference between Modified SASI and AHI in strength of association with mean arterial pressure.
Sensitivity analysis was performed for bootstrapping with different numbers of repetitions, using the same seed value and per-repetition sample size as the main analysis. Bootstrapping with 10, 50, 1000, and 10,000 repetitions produced nearly identical correlation coefficient estimates, confidence intervals, and P values (data not shown).
Discussion
The current measure used to assess obstructive sleep apnea severity is AHI, a physiologic measure. Although some studies support relationships between AHI and self-reported health status 14 or daytime sleepiness, 15 others show poor associations between AHI and subjective and objective measures of disease burden. 3, 4 The apnea-hypopnea index also has limitations as an outcomes measure. A meta-analysis of surgical interventions for sleep apnea, for example, found that AHI outcomes and subjective outcomes followed different patterns. 5 Previous studies of various therapies have showed little association between change in AHI and change in quality of life or other subjective and objective outcomes. 4, 16 Thus, AHI may be an incomplete measure of disease severity for clinicians and researchers interested in disease burden and therapeutic effects as experienced by patients. Our results support this conclusion, suggesting that physiologic measures are not consistently associated with each other or with subjective measures. However, AHI has some prognostic value. It is associated with hypertension, [17] [18] [19] other markers of cardiovascular risk, 20 and cardiovascular outcomes. 21, 22 In this study, AHI showed significant associations with serum C-reactive protein and mean arterial blood pressure, 2 surrogate measures of cardiovascular risk and mortality risk. 23, 24 Meanwhile, commonly used subjective disease burden measures may also not reflect the breadth of this disease. As mentioned, associations are inconsistent between AHI and patients' subjective complaints, and the same holds true for other combinations of objective and subjective measures. 25 Ideally, assessment of disease severity, burden, and outcome should incorporate multiple relevant variables. For example, cancer staging uses disease-specific combinations of tumor size and nodal and distant metastasis. The SASI and Modified SASI may play a similar role in assessing baseline sleep apnea disease burden, combining diverse subjective and objective elements into a simple score. SASI has been shown to have some such utility; in its original description, scores showed dose-response relationships with multiple aspects of health status measured by the SF-36. 8 Meanwhile, because SASI incorporates anatomic and physiologic variables, including AHI, it may associate with physiologic aspects of sleep apnea and their clinical sequelae.
To our knowledge, this study is the first to validate any composite adult sleep apnea severity indices across subjective and objective measures of disease burden. Furthermore, it is the first to test the prognostic value of composite indices for the broader disease burden of sleep apnea, particularly potential cardiovascular disease risk and mortality risk as reflected by the surrogate measures 3% desaturation index, mean arterial pressure, and serum C-reactive protein.
This study supported our hypothesis that SASI and Modified SASI, as composite measures, reflect sleep apnea disease burden more thoroughly than the isolated physiologic AHI measure. Relationships with subjective construct measures were statistically significant and also clinically important (especially with sleep apnea-specific quality of life, the most disease specific of our subjective measures, and our primary construct defined a priori) or nearly so. Meanwhile, these 2 indices also reflected the breadth of objective disease burden well.
Modified SASI, using tonsil size instead of pharyngeal mucosal redundancy, may be more useful because it is easier to use and is based on a standardized measure of anatomic upper airway obstruction. Anecdotally, our research assistants found assessment of pharyngeal mucosal redundancy more vague, and thus more challenging, than standardized tonsil grading, despite having written and photographic descriptions of each. Dichotomization of tonsil size in the Modified SASI was based on a preliminary analysis demonstrating that none of the construct variables, AHI, or body mass index had significantly different distributions when comparing 0-1 vs 2-4 or 0-2 vs 3-4 dichotomization, and based on evidence that AHI is similar in tonsil grades 0 and 1 but rises between 1 and 2. 26 We addressed the complexity of sleep apnea as a disease by validating the SASI, Modified SASI, and AHI across 7 validation measures selected a priori to reflect disease-specific and general subjective burden, short-term physiologic burden, and long-term cardiovascular and mortality risk. The use of 7 validation measures raises the specter of false-positive findings due to multiple testing, but by choosing these measures in advance and by using a stricter significance level, the problems of multiple testing are minimized.
In interpreting our findings, it is important to distinguish between statistically significant and clinically important results. In this study, our predetermined cutoff for clinical importance was |r| ≥ 0.25. The 2 composite indices exceed or approach this number more than does AHI for most of our validation measures. Indeed, the composite indices appear to maintain all or most of AHI's association with the desaturation index and mean arterial pressure while capturing additional subjective burden. Along the same lines, although AHI was statistically more significantly associated with SF-36 mental health status than either SASI or Modified SASI, the absolute strengths of all 3 associations were very weak, so this comparison is not useful.
The 3-point scale of SASI and Modified SASI is a potential limitation, lacking the granularity of a continuous variable. However, for disease staging, a 3-point scale may be clinically easy and useful. Similarly, although TNM staging produces many combinations of tumor, nodal, and metastatic status, it is reduced to a limited ordinal scale (I-IV). Although a more granular scale might be produced for SASI, it would likely require very large samples to stratify multiple combinations of the scoring elements.
The study has other limitations. Complete data were not available for all participants, creating possible reporting bias by analyzing only those with complete data. However, the analyzed sample appears similar to those not analyzed. Our AHI definitions were based on criteria at the time in our sleep center. Since these data were collected, our center has adopted the definitions since recommended by the American Academy of Sleep Medicine. 27 It is possible that the newer definitions translate to a more robust AHI measure of disease burden. However, since the definitions did not change drastically and since SASI and Modified SASI also include AHI, it appears unlikely that this change will differentially improve AHI performance over SASI or Modified SASI. Our objective measures of disease burden are all surrogate measures of clinical outcome. It would be better to measure the clinical outcomes themselves (eg, future incident cardiovascular disease and mortality); however, those long-term prospective measurements were beyond the scope of this cross-sectional study.
With regard to this study's generalizability, our study sample is similar to the general sleep apnea population; a random telephone survey matched to US-wide regional age distributions found that men were generally at higher risk than women, ages 50 to 64 years were at highest risk, and risk rose markedly with body mass index ≥30. 28 However, our predominantly white sample may not reflect sleep apnea prevalence patterns in other racial groups. 29, 30 
Conclusion
Sleep apnea is a complex disease with important subjective and objective components. Although patients seek care for subjective complaints, physicians and researchers often focus on objective measures, specifically AHI. Although AHI has value in the diagnosis and evaluation of sleep apnea, this study suggests that composite indices may be useful adjuncts in baseline assessment, prognostication, and outcomes assessment of these patients by clinicians and researchers. Studies currently under way are examining the utility of such indices in predicting and assessing therapeutic effects and disease changes over time.
